Drugs for the treatment of membranous nephritis include angiotensin-converting enzyme inhibitors (e.g., Benadryl) or angiotensin II receptor antagonists (e.g., valsartan), glucocorticoids (e.g., prednisone), immunosuppressants (e.g., cyclophosphamide, tacrolimus), and rituximab. Attention is also given to anticoagulant therapy such as warfarin and low molecular heparin. Also included are lipid-regulating drugs such as atorvastatin. 1. Angiotensin converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (ARB): such as Benadryl and Valsartan, to control blood pressure, correct lipid metabolism disorders and prevent venous thrombosis, in order to achieve the reduction of proteinuria, delay the onset of renal insufficiency, and reduce cardiovascular complications. 2. Glucocorticoid: commonly used drugs are methylprednisolone, prednisone acetate, etc., which generally need to be combined with immunosuppressants (such as cyclophosphamide, tacrolimus) and other drugs. 3. Immunosuppressants: immunosuppressants (e.g. cyclophosphamide, tacrolimus, cyclosporine) and so on. Generally need to be combined with glucocorticoid therapy, clinically tacrolimus can also be used alone. 4. Rituximab can be used for treatment of patients with recurrent relapses or in the middle or high risk groups. 5. Anticoagulation therapy: use warfarin, low molecular heparin, rivaroxaban, etc. to prevent thrombosis. 6. Lipid-regulating treatment: lipid-regulating drugs such as atorvastatin. Membranous nephropathy patients are recommended to consult regular hospitals and standardize the treatment under the guidance of physicians.